Sigma Pharmaceuticals buys Discount Drug Stores for $26.7m
SIGMA Pharmaceuticals, one of Australia’s largest listed pharmacy brands, has acquired the Discount Drug Stores portfolio for $26.7 million. The deal will add 121...
Mylan Launches Generic Boniva® Injection
Mylan Inc. (MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled glass syringes,...
Chicago misses out in AbbVie-Calico pharma deal
A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility to invent new drugs...
Navidea signs China commercialization deal for Lymphoseek
Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive rights bring the drug...
Chicago misses out in AbbVie-Calico pharma deal
A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility to invent new drugs...
Navidea signs China commercialization deal for Lymphoseek
Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive rights bring the drug...
Jinan Asia Pharmaceutical Opens US Branch
Jinan Asia Pharmaceutical (JAP) opened an office in Irvine, California and introduced the newly formed HL-Pharma USA Corporation. JAP is one of the global...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...